StockTipsArenaBeta

BUY Gland Pharma Limited — Sumeet Bagadia, Choice Broking

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))30 Jul 2026via LiveMint Buy-or-Sell (topic)

Entry₹2,544Stated
Target₹2,720
Total upside +6.92% (call closed)
Stop loss₹2,434-4.32% risk
Exit₹2,72011 Aug 2026, 9:15 am
Target hit+6.92%0.00%upside left
Follow Sumeet Bagadia for new calls(28% target hit, 411 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 152 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Aug 2026
10 supporting1 neutral2 opposing
Supports the BUY call (10)

Gland Pharma Delivers Q1 Earnings Beat On US, Europe Strength; Motilal Oswal Raises Estimates — Check New Target Price

NewsNdtv-Profit·11 Aug · today

(opens in new tab)

Gland Pharma Q1 Results: Profit Spikes 47% As Margins Expand; Revenue Hits Rs 1,800 Crore

NewsNdtv-Profit·10 Aug · today

(opens in new tab)

Gland Pharma Q1 net profit jumps 47% on strong CDMO, B2B performance; revenue up 20%

NewsCnbc-Tv18·10 Aug · today

(opens in new tab)

Gland Pharma Q1 Results: Net profit jumps 47% YoY to ₹317 crore; CDMO revenue rises 20%

NewsLivemint·10 Aug · today

(opens in new tab)

Gland Pharma reported Q1FY27 financial results, showing a 20% year-on-year revenue growth and a 47% year-on-year PAT growth. The company highlighted strong performance driven by its CDMO strategy and

BSE · Company Update·10 Aug · today

(opens in new tab)
Neutral / worth noting (1)

Gland Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·10 Aug · today

(opens in new tab)
Weighs against the BUY call (2)

Q1 Results Today Highlights: Bharat Forge shares tank after Q1 loss, Kwality Pharma, Ramco Industries Q1 PAT up, Hindustan Copper PAT down q-o-q, AstraZeneca, Info Edge & Astra Microwave profit dip, Vi, Bosch, Lloyds Metals, Gland Pharma, Zee Entertainment, KEC International to announce Q1 results

NewsHbl·10 Aug · today

(opens in new tab)

Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

NewsNdtv-Profit·22 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Sumeet Bagadia, Choice Broking

Every call and its outcome